Advertisement

Topics

Susan G. Komen and Pfizer Company Profile

21:24 EDT 19th April 2018 | BioPortfolio

Susan G. Komen is the world's largest breast cancer organization, funding more breast cancer research than any other nonprofit outside of the federal government while providing real-time help to those facing the disease. Komen has set a Bold Goal to reduce the current number of breast cancer deaths by 50 percent in the U.S. by 2026. Since its founding in 1982, Komen has funded more than $956 million in research and provided more than $2.1 billion in funding to screening, education, treatment and psychosocial support programs serving millions of people in more than 30 countries worldwide. Komen was founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life. That promise has become Komen's promise to all people facing breast cancer. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at ww5.komen.org/social.


News Articles [887 Associated News Articles listed on BioPortfolio]

Cypress Bayou Casino Hotel Donates Over $28,000 to Komen Acadiana

Cypress Bayou Casino Hotel joined Susan G. Komen for the Cure Acadiana this morning in Lafayette to present a donation of $28,567 marking the fifth straight year Cypress Bayou Casino Hotel partnered w...

Susan G. Komen and Pfizer Team Up To Support Metastatic Breast Cancer Patients and Caregivers in the U.S. with Educational Series

Susan G. Komen® has partnered with Pfizer®, one of the world’s premier biopharmaceutical companies, to present a line-up of educational events, held in local communitie...

Susan G. Komen®-Funded Study Shows Promise of Using Circulating Tumor Cells to Determine Risk of Breast Cancer Recurrence

Predicting whether breast cancer will recur may one day be as simple as a blood test, thanks to pioneering research led by Joseph A. Sparano, M.D., presented today at the 40th ann...

Susan G. Komen®, Milburn Foundation and Inflammatory Breast Cancer (IBC) Research Foundation Join Forces, Raising Funds, Awareness, for IBC

For the third year in a row, donors can have their breast cancer donations and impact doubled thanks to the Milburn Foundation, Inflammatory Breast Cancer Research Foundation, and...

Susan G. Komen® Welcomes Leaders in Health Equity, Novel Therapeutics, Bioinformatics and Advocacy to Renowned Breast Cancer Research Program

The world’s largest non-profit funder of breast cancer research, Susan G. Komen, today announced new advisory roles for 12 renowned leaders in breast cancer. These women and men...

VBL Therapeutics Announces the Appointments of Susan Kelley and David ...

VBL Therapeutics , today announced the appointments of both David Hastings and Susan Kelley, M.D. to its Board of Directors. Susan L. Kelley, M.D. is an oncologist with extensive experience in drug de...

Susan Collins Never Had An Actual Deal On Taxes

WASHINGTON ― Before she voted for the Senate version of the Republican tax bill, Sen. Susan Collins saw that Congress would soon be passing separate spending deals, and she had demands.

Biosimilars Council Sides with Pfizer in Antitrust Dispute with J&J

As we previously reported , on September 20, 2017, Pfizer filed an antitrust lawsuit against Johnson & Johnson in the U.S. District Court for the Eastern District of Pennsylvania alleging that J&a...

Drugs and Medications [97 Associated Drugs and Medications listed on BioPortfolio]

Preparation h [Pfizer Consumer Healthcare]

Preparation H Suppositories(cocoa butter and phenylephrine HCl)

Chapstick overnight [Pfizer Consumer Healthcare]

ChapStick Overnight Lip Treatment (dimethicone)

Preparation h [Pfizer Consumer Healthcare]

Preparation H Hemorrhoidal Ointment (mineral oil, petrolatum and phenylephrine HCl)

Anbesol cold sore therapy [Pfizer Consumer Healthcare]

Anbesol Cold Sore Therapy(allantoin, benzocaine, camphor, and white petrolatum)

Chapstick lipshield 365 [Pfizer Consumer Healthcare]

Chapstick LipShield 365(avobenzone, dimethicone, homosalate, octinoxate, octisalate, and oxybenzone)

PubMed Articles [10 Associated PubMed Articles listed on BioPortfolio]

Corrigendum.

Vila PM, Zenga J, Fowler S, Jackson RS. Antibiotic prophylaxis in clean-contaminated head and neck surgery: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2017;157:580-588. (Origin...

Water Analysis: Emerging Contaminants and Current Issues.

This biennial review covers developments in water analysis for emerging environmental contaminants over the period of October 2015-October 2017. Analytical Chemistry's policy is to limit reviews to a ...

Award for Distinguished Contributions to the International Advancement of Psychology.

This award is given to individuals who have made sustained and enduring contributions to international cooperation and the advancement of knowledge in psychology. The 2017 recipient of the APA Award f...

Ertugliflozin: First Global Approval.

Ertugliflozin (Steglatro™) is an orally active sodium glucose co-transporter type 2 inhibitor being developed by Merck and Pfizer as a treatment for type 2 diabetes mellitus (T2DM). Ertugliflozin as...

International Humanitarian Award.

The International Humanitarian Award recognizes extraordinary humanitarian services and activism by psychologists, including professional and volunteer work conducted primarily in the field with under...

Clinical Trials [83 Associated Clinical Trials listed on BioPortfolio]

Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)

This extension study will evaluate the safety (including immunogenicity) of treatment with rituximab-Pfizer, as well as the safety and immunogenicity after transitioning from rituximab-US ...

A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy Subjects

The primary objective of the study is to determine bioequivalence of 50 mg (2x25 mg) Artesunate Sachet (Pfizer) versus 50 mg (1x50 mg) tablet, Arsuamoon® (Guilin China) which is the World...

A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))

This is a Phase 1, double blind (sponsor open), randomized (1:1:1), parallel group, 3 arm, single dose comparative PK study of adalimumab Pfizer and adalimumab sourced from the US and EU a...

A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects

The study will determine if amodiaquine tablet (Pfizer), an antimalaria agent, is pharmaceutically equivalent to a comparator product (Arsuamoon-Guilin China).

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions

An open label, randomized, single-center, single-dose, two-treatment, two-period, crossover bioavailability study comparing Cetirizine Hydrochloride 10 mg tablet of Ohm Laboratories Inc. ...

Companies [176 Associated Companies listed on BioPortfolio]

Susan G. Komen and Pfizer

Susan G. Komen is the world's largest breast cancer organization, funding more breast cancer research than any other nonprofit outside of the federal government while providing re...

Susan G. Komen for the Cure® Advocacy Alliance

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the ...

Susan G. Komen for the Cure, Tulsa Affiliate

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched th...

Susan G. Komen for the Cure and Dallas Cowboys

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the ...

Susan G. Komen for the Cure Advocacy Alliance

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer. Today, Susan G. Komen for the Cure® works to end breas...

More Information about "Susan G. Komen and Pfizer" on BioPortfolio

We have published hundreds of Susan G. Komen and Pfizer news stories on BioPortfolio along with dozens of Susan G. Komen and Pfizer Clinical Trials and PubMed Articles about Susan G. Komen and Pfizer for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Susan G. Komen and Pfizer Companies in our database. You can also find out about relevant Susan G. Komen and Pfizer Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record